In previously published studies, we have demonstrated that miR-23b directly targeted both MET and uPA in HCC cells and that the ectopic expression of miR-23b reduced proliferation and migration abilities of HCC cells [23]. The gene discussed is MET; the disease is hepatocellular carcinoma.